JPMorgan raised the firm’s price target on Grifols to EUR 10 from EUR 9 and keeps a Neutral rating on the shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on GRFS:
- Grifols completes cohort 1 in study of Alpha-1 15%
- Grifols price target lowered to EUR 11 from EUR 11.50 at Barclays
- GigaGen presents IND-enabling data, Phase 1 trial strategy for GIGA-564
- Is GRFS a Buy, Before Earnings?
- Araclon Biotech Presents Positive Final Results from Phase 2 Clinical Study of ABvac40 Alzheimer’s Vaccine at CTAD